Skip to content
WeighLab
Menu
Ranked #318 · Grade C

NowPatient review

NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

Visit NowPatient Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$1,349/mo (brand Wegovy)
Tirzepatide
$1,069/mo (brand Mounjaro, promotional rate)
Coverage
Coverage not published
Brand-name
Yes

Semaglutide · modeled / year

$16,188

Tirzepatide · modeled / year

$12,828

The Index scorecard

NowPatient scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month49/100
Price Transparency38/100
Nationwide Access24/100
Formulation Options95/100
Clinical Oversight85/100
Contract Flexibility55/100

Where the value is

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

The tradeoffs

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

The bottom line

Best for: Cost-first shoppers who want brand-name GLP-1 access without a compounded route. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

Ranked #318 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to NowPatient.

The 18 programs nearest this one

Pricing, states and verification reflect NowPatient's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on NowPatient's site. Not medical advice; see our disclosure.

← Back to the value leaderboard